Portal de Periódicos da CAPES

Efficacy of daptomycin in the treatment of enterococcal endocarditis: a 5 year comparison with conventional therapy

2014; Oxford University Press; Volume: 69; Issue: 6 Linguagem: Inglês

10.1093/jac/dku004

1460-2091

Inés Cerón, Patricia Muñóz, Mercedes Marín, A. Segado, J. Roda, Maricela Valerio, Emilio Bouza, Javier Bermejo, Emilio Bouza, Alia Eworo, Ana Fernández‐Cruz, Gregorio Cuerpo, José Antonio García Robles, Marcela González del Vecchio, Ana García Mansilla, Víctor José González Ramallo, Martha Kestler, Mercedes Marín, Manuel Martínez‐Sellés, Ma Cruz Menárguez, Patricia Muñóz, Enrique Pérez Gutiérrez, B. Pinilla, Ángel Pinto, J. Roda, Marta Rodríguez‐Créixems, Hugo Rodríguez, Manuel Ruiz‐Aravena, Maria Aurora Posadas Salas, A. Segado, Maricela Valerio, Pilar Vázquez, Eduardo Verde,

Streptococcal Infections and Treatments

ObjectivesEnterococcus spp. account for 10% of infective endocarditis (IE). Although daptomycin is a bactericidal drug with in vitro activity against Enterococcus, there is little experience of its use in IE. We analysed the effectiveness of daptomycin in the treatment of enterococcal IE (EIE).